Urologix, Inc. (ULGX) Reports Q3 Loss of $0.07/Share; Revs Improve
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Price: $0.00 --0%
Financial Fact:
Research and development: 298K
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Research and development: 298K
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Urologix, Inc. (NASDAQ: ULGX) reported Q3 EPS of ($0.07), versus ($0.07) reported last year. Revenue for the quarter came in at $4.74 million, versus $2.98 million reported last year.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Mangoceuticals closes $500K offering at 74% premium to recent price
- Bernstein SocGen: 'MediaTek Inc. (2454:TT) (MDTKF) is our Top Pick and the recent pullback provides a good setup'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
